Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Interim 18F-FLT PET/CT in Pancreatic Adenocarcinoma
NCT03318497Phase 2Completed
- Sponsor
- UT Southwestern Medical Center
- Start
- Dec 2017
- Primary completion
- Jun 2021
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial, sponsored by UT Southwestern Medical Center. Primary endpoints: Change From Baseline in Summed Standardized Uptake Value (SUVmax) of Lesion, Change From Baseline in SUV Peak of Lesion and 2 more. Started Dec 2017; status: completed.
Beyond the preview
Go deeper on NCT03318497.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03318497.